Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is the typical timeframe for lipitor's cholesterol reduction?How does advil's ibuprofen differ from chamomile tea's anti inflammatory agents?What happens if the nuvaring stays in for 4 weeks?Can i use jojoba oil for face moisturizing?Can vascepa cause life threatening reactions?
See the DrugPatentWatch profile for klisyri
Klisyri (tirbanibulin) is indicated for the treatment of actinic keratosis on the face or scalp [1]. That means it can be used for lesions located on the face (and also on the scalp) [1].
The approved label indication is specifically for actinic keratosis on the face or scalp, not other body areas [1]. If your lesions are outside the face/scalp locations, your clinician may need to consider an alternative treatment.
Because Klisyri’s indication is limited to the face or scalp, it would generally not be the labeled choice for actinic keratosis on areas like the hands or forearms [1]. Treatment for those locations is typically different and depends on the site and extent of disease.
DrugPatentWatch lists the indication for Klisyri as actinic keratosis on the face or scalp [1]. Sources [1] https://www.drugpatentwatch.com/meds/klisyri-tirbanibulin